Trident Lifeline Ltd

Trident Lifeline Ltd (TLL) is a micro-cap Healthcare company valued at ₹481 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Trident Lifeline Ltd last traded at ₹402, down 4.26% on the day.

Recent developments

On 2026-09-30, the promoter holding decreased by 0.13 percentage points, reflecting a minor shift in ownership. Foreign institutional holding fell by 4.09 percentage points in the quarter, while domestic institutional holding dropped by 0.05 percentage points.

Financial performance

The company's business is improving, with annual revenue rising 48.4% and annual net profit growing 62.0%. The latest quarter saw revenue increase 42.8% compared to the same quarter a year earlier, while net profit rose 64.4%, indicating strong growth in both revenue and profitability.

Valuation multiples

The stock trades at 24.6 times earnings, a discount to the Healthcare median of 32.0, 3.52 times book value.

Things to watch

The stock is 1.2% below its 52-week high, indicating a recent pullback. Promoter shares pledged account for 11.29% of promoter holding, which could signal liquidity concerns. The company's debt to equity ratio is 0.73, suggesting moderate leverage.

Where it stands

Trident Lifeline Ltd has shown strong growth in both revenue and net profit over the past year and quarter, with net profit margins improving. The stock is currently 1.2% below its 52-week high, and promoter shares pledged represent 11.29% of promoter holding.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.